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Abstract. Aortic valve replacement has been recom-
mended in patients who have severe symptoms, in
patients with extreme left ventricle (LV) dilatation
(end diastolic dimension >4 SD above normal) or
LV ejection fraction <50%. However, the occurrence
of advanced symptoms or severe LV dilatation raises
concern about irreversible LV dysfunction. This
study sought to determine the inﬂuence of pre-
operative symptoms, LV size and function on mor-
tality, and postoperative LV performance in children
and adolescence after valve replacement for aortic
regurgitation (AR). A total of 49 patients 18 years
old or younger (mean, 13.9 ± 3) who underwent
valve replacement for chronic AR between 1991 and
2001 were followed up for 1–10 years (mean,
3.3 ± 2.1). Baseline and postoperative characteristics
were compared between 13 patients (group 1) with
extreme LV dilatation and 34 patients (group 2) with
a lesser degree of LV enlargement. Preoperative low
ejection fraction (p < 0.008), extreme LV dilatation
(p < 0.05), and LV end systolic dimension >4 SD
above normal (p< 0.05) were predictors of persistent
LV dysfunction. Extreme LV dilatation (p <
0.0003), LV end systolic dimension (p< 0.0007), and
reduced LV ejection fraction (p < 0.01) predicted
persistent LV dilatation. In the setting of chronic AR,
preoperative symptoms, LV systolic function, and LV
internal dimensions are the main predictors for per-
sistent LV dysfunction and dilatation. Surgical cor-
rection should be performed before LV systolic
dysfunction and/or extreme LV enlargement occurs.
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Aortic regurgitation (AR) can be corrected success-
fully with aortic valve replacement (AVR). Because
of the relatively high incidence of postoperative left
ventricular (LV) dysfunction, objective indexes of LV
size and function have been recommended to guide
the timing of AVR [1, 5, 7, 11, 13]. Despite some
controversy, it is a common belief that surgery for
chronic AR should be performed before a consider-
able decrease in systolic function and severe
enlargement of the LV has occurred, even in
asymptomatic or mildly symptomatic patients [1, 3, 5,
7, 11, 13]. Additionally, there are a group of patients
with chronic severe AR who are symptomatic [New
York Heart Association (NYHA) functional class
III/IV] and thus need valve replacement irrespective
of LV size [8, 13].
Despite several previous studies on the evalua-
tion of the predictive value of clinical and echo-
cardiographic parameters, appropriate timing of
surgery is still a controversial and sensitive issue [5,
7, 11, 13]. Because of the physical growth of chil-
dren, early operation increases the possibility for a
later operation, which will be more risky and haz-
ardous. On the other hand, potential beneﬁts of
surgical intervention cannot be attained when cor-
rective surgery is performed too late and such pa-
tients are at risk of persistent LV dilatation and
progressive heart failure. Accordingly, making
appropriate decisions regarding surgical timing for
children is more diﬃcult than for adults. However,
a number of previous reports have evaluated the
importance of clinical and hemodynamic parameters
in adults, who usually suﬀer from multiple other
pathologic conditions (e.g., coronary artery disease,
diabetes mellitus, and hypertension). The American
College of Cardiology and the American Heart
Association published the guidelines for the man-
agement of patients with valvular heart disease [2].
According to this guideline, the indication for sur-
gery in children with isolated AR is similar to that
for adults; that is, NYHA functional class III/IVCorrespondence to: R.I. Tafreshi, email: tafreshi@iums.ac.ir
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symptoms, LV dysfunction (LV ejection fraction
<50%), or progressive LV enlargement (end dia-
stolic dimension >4 SD above normal for body
surface area and weight). To our knowledge, post-
operative improvement of symptoms and ventricular
function were not completely evaluated. Thus, we
evaluated the importance of preoperative clinical,
hemodynamic variables for persistent ventricular
dysfunction after aortic valve replacement in chil-
dren and adolescents. In this study, we attempt to
determine the appropriate timing of aortic valve
replacement irrespective of etiology of aortic re-
gurgitation, before irreversible myocardial damages
develop.
Materials and Methods
Patients enrolled in this study all had the following criteria: (1)
18 years of age or younger; (2) chronic severe AR as diagnosed
by echocardiography and aortography (grade III/IV regurgita-
tion); (3) surgical replacement of aortic valve in our institution
between 1991 and 2001; (4) adequate preoperative echocardiog-
raphy, with dimension and function measured within 3 months of
operation; and (5) postoperative echocardiography, with internal
LV diameters and function measured approximately 1 year after
surgery. Excluded were those patients with (1) associated signif-
icant aortic stenosis (a pressure gradient exceeding 40 mmHg),
(2) concomitant moderate mitral or tricuspid valve regurgitation
or stenosis; and (3) large ventricular septal defect (VSD) with
signiﬁcant left-to-right shunt (QP/QS > 2/1). Patients who
underwent aortic root replacement at the time of AVR were not
excluded.
Echocardiographic evaluation was performed a median of 25
days (up to 3 months) before the operation. Because of known
gradual postoperative improvement of LV internal diameters and
function, the echocardiograms used for analysis of these parame-
ters were obtained approximately 1 year after operation (mean, 405
days). Standard echocardiographic studies were carried out
according to the American Society of Echocardiography recom-
mendations [12]. M-mode measurements of LV internal dimensions
and ejection fraction (EF) were guided by two-dimensional echo-
cardiography. For each case, normal limits of ventricular diameter
(mean value ± SD) were calculated using the equation introduced
previously [6]. The echocardiographic data of patients were com-
pared against nomograms [12]. In our study, similar to previous
reports, LV end diastolic dimension >4 SD above normal was
considered as extreme LV dilatation [3, 5, 7, 12]. Then, patients
were divided into two groups on the basis of LV end diastolic
dimension. Patients with extreme LV dilatation were classiﬁed in
group 1. Patients with lesser degrees of LV enlargement were
considered as group 2. Postoperative end diastolic dimension
greater than tolerance limit for weight and age was considered as
persistent LV dilatation [6, 7, 12]. Postoperative LV dysfunction
was deﬁned as the presence of cardiac failure or LVEF<50% [3, 5,
11]. NYHA functional class was determined according to symp-
toms and functional impairment at the time of preoperative eval-
uation regardless of previous symptoms and history. Follow-up
was completed for patients up to 2001 or death. Operative mor-
tality was deﬁned as death occurring within the hospitalization
period or within 30 days of operation.
Statistical Analysis
Group statistics were expressed as mean value ± SD. Between-
group comparison of the changes in LV echocardiographic vari-
ables from preoperative to postoperative measurements were car-
ried out using one-way analysis of variance for repeated
measurements and a group variable. Group comparisons (group 1
vs group 2) were performed with a standard t-test, Chi–square test,
or Fisher’s exact test, when appropriate. The endpoints were
operative mortality (death occurring within 30 days after opera-
tion), postoperative EF <50%, and residual LV dilatation (dia-
stolic dimension above tolerance limit for age and weight).
Operative mortality was compared between the two groups with
the Fisher’s exact test. Multivariate analyses were performed with
the clinical and echocardiographic variables as independent vari-
ables and the presence of LV dysfunction and persistent LV dila-
tation as dependent variables. p< 0.05 was considered statistically
signiﬁcant.
Results
Preoperative clinical, echocardiographic, and hemo-
dynamic characteristics of the patients are summa-
rized in Table 1. Of 75 patients who underwent valve
replacement for severe aortic regurgitation during the
study period, 49 met the entry criteria. Among these
49 patients, 13 [26.5% (group 1)] displayed a preop-
erative diastolic dimension >4 SD above normal
(median, 61 mm; mean, 65.1 ± 8.5; range, 53–80),
whereas the remaining 36 patients [73.5% (group 2)]
had smaller preoperative diastolic dimensions (med-
ian, 47 mm; mean, 46.4 ± 8.7; range, 40–54). The
age of the patients at the time of operation ranged
between 7 and 18 years (mean, 13.9 ± 3). Five pa-
tients [10.2% (all in group 2)] were in NYHA func-
tional class I, 36 [73.5% (6 in group 1)] in class II, 7
[14.3% (6 in group 1)] in class III, and 1 [2% (in group
1)] in class IV. All patients were in sinus rhythm.
History of overt chronic heart failure was present in 1
patient in group 1. There was not any associated
systemic disease in our series. In all patients, valve
replacement with mechanical prostheses was per-
formed.
Etiology
The origin of AR was rheumatic in 40.8% (20 pa-
tients). History of previous commissurotomy for
aortic stenosis and progressive AR was available in
30.6% (15 patients) and in 50.3% the aortic valve was
bicuspid. Aortic valve prolapse through a subaortic
or subpulmonic VSD and severe AR were present in
14.3% (7 patients). Annuloaortic ectasia (e.g., Mar-
fan’s syndrome) was noted in 6.1% (3 patients), dis-
crete subaortic obstruction damaging the aortic valve
was found in 4.1% (2 patients), and rupture of sinus
of valsalva was noted in 4.1% (2 patients). Surgical
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interventions on the ascending aorta were performed
in 3 patients. Aortic valve replacement was per-
formed after valvular commissurotomy at an interval
of 4 years (range, 2–9).
Surgical Mortality and Complication
The mean follow-up period was 3.3 ± 2.1 years
(2.4 ± 2.1 years in group 1 and 3.2 ± 1.8 years in
group 2). The overall mortality rate was 8.1% [four
patients (two in each group)] (Table 1). Surgical
mortality was not diﬀerent between groups. Death
was due to low cardiac output in three patients and
hemorrhage and multiorgan failure in one patient.
Among them, preoperative NYHA functional class
III was present in three (75%) patients, mean LVEF
was 52.5 ± 2%, and mean LV end diastolic and end
systolic dimensions were 55.7 ± 8.1 and
40 ± 5.2 mm (<4 vs >3 SD above normal), re-
spectively. In the combined multivariate analysis
(Table 2), only NYHA functional class III/IV was
independently predictive of operative mortality (p <
0.04). Surgical complete heart block was noted in two
patients (4.1%). During follow-up, the prosthetic
valve had to be replaced in two patients (4.1%) be-
cause of bacterial endocarditis in one case and pros-
thetic valve malfunction secondary to thrombus
formation in the other.
Postoperative Characteristics
A total of 45 patients underwent echocardiography
approximately 1 year after AVR, including 11 pa-
tients in group 1 and 34 patients in group 2. Echo-
cardiographic characteristics and changes are
summarized in Table 3.
Table 1. Clinical and echocardiographic characteristics of study patientsa
Variable
Grouo 1 (preop LVD >4 SD
above normal) (n = 13)
Group 2 (preop LVD <4 SD
above normal) (n = 36) p value
Male 10 (76.4) 26 (72.2) NS
Age (Years) 14.5 ± 3.2 12.8 ± 4.5 NS
NYHA III/IV 7 (53.8) 1 (2.7) 0.05
Hx of CHF 1 (7.6) 0 (0) NS
LVDD (mm) 65.1 ± 8.5 46.4 ± 8.7 0.005
LVSD (mm) 44.5 ± 8b 29.7 ± 4.4c NA
EF (%) 54.8 ± 9.6 69.2 ± 8.1 0.05
Operative mortality 2 (15.3) 2 (5.5) NS
Mean duration of follow-up (years) 2.4 ± 2.1 3.2 ± 1.8 NS
NYHA, New York Heart Association functional class; HX of CHF, history of congestive heart failure; LVDD, left ventricular end diastolic
dimension; LVDD, left ventricular end systolic dimension; EF, ejection fraction; NA, not applicable; NS, not signiﬁcant; preop, preop-
erative.
a Data presented are mean values ± SD or number (%) of patients.
b LVSD >4 SD above normal.
c LVSD <3 SD above normal.
Table 2. Multivariate predictors of clinical outcomes in patients undergoing aortic valve replacement for chronic severe aortic regurgitation
p valuea
Variable Operative mortality NYHA class III/IV Postop EF Postop LVDD >tolerance limits
Clinical
NYHA III/IV 0.04 NS NS NS
Hx of CHF NA NS NS NS
Echocardiographic
LVEF <50% NS 0.03 0.008 0.01
LVDD >4 SD NS NS 0.05 0.0003
LVSD >4 SD NS 0.02 0.05 0.0007
NYHA, New York Heart Association functional class; Hx of CHF, history of congestive heart failure; EF, ejection fraction; LVDD>4 SD,
left ventricular end diastolic dimension >4 SD above normal; LVSD>4 SD, left ventricular end diastolic dimension >4 SD above normal;
Postop, postoperative; NA, not applicable; NS, not signiﬁcant.
a p < 0.05 is signiﬁcant in predicting outcome in combined multivariate model.
Tafreshi et al.: Predictors of Left Ventricular Performance After Valve Replacement 333
LV Function.. The postoperative improvement in
EF was only signiﬁcant in group 2. Persistently de-
pressed postoperative EF (<50%) was present in 18%
of patients in group 1 (2 of 11 patients). In multi-
variate analysis (Table 2), preoperative low LVEF
(p < 0.008) and LV internal diameter >4 SD above
normal were signiﬁcant independent predictors of
postoperative LV dysfunction (p < 0.05).
LV Internal Diameters. Postoperative LV end sys-
tolic dimension in group 1 was signiﬁcantly greater
than that in group 2 (>4 vs <1 SD above normal)
(p < 0.005). Signiﬁcant regression was noted in the
end diastolic dimension postoperatively. However,
regression was more pronounced (p < 0.08) in
group 1 than in group 2 (p < 0.05). Multivariate
analysis revealed that preoperative LV end systolic
dimension (p < 0.0007), LV end diastolic dimension
(p < 0.0003), and LVEF (p < 0.01) were correlated
positively with residual postoperative LV dilatation
(Table 2).
Clinical Status. At follow-up of both groups, two
patients (18%) in group 1 and three patients (8.8%)
in group 2 were in NYHA functional class III/IV
(p < 0.05). In the combined multivariate analysis of
clinical and echocardiographic variables, pre-
operative EF (p < 0.03) and LV end systolic di-
mension (p < 0.02) were signiﬁcant independent
predictors of postoperative functional class III/IV
(Table 2). Diastolic dimension was not predictive of
advanced clinical symptoms.
Discussion
Optimal timing of valve replacement for chronic
aortic regurgitation has been and still is a contro-
versial issue. Poor results after valve replacement
have been demonstrated not only in preoperatively
symptomatic patients but also in patients with de-
creased LV function [5]. Previous studies revealed
that the development of signiﬁcant symptoms (de-
ﬁned as NYHA functional class III/IV) is associated
with a grim prognosis and widely accepted as a strong
indication for operation [4, 5, 13]. However, the
ﬁnding of LV dysfunction has led to the suggestion
that objective measurements of LV status should also
be used to guide the timing of operation irrespective
of symptoms [1, 3, 5, 7, 11, 13]. Because most previ-
ous studies were performed on adults, we sought to
determine the predictive value of preoperative func-
tional impairment and LV size and function in
postoperative persistent ventricular dysfunction and
dilatation in children and adolescents. Thereby, we
will be able to determine appropriate timing of valve
replacement that is neither too late so that irreversible
myocardial damage is established nor too early so
that patients are subjected to multiple risks of reop-
eration.
Etiology and Preoperative Characteristics.
Similar to previous reports, the most common cause
of chronic AR in this study was rheumatic heart
disease (40.8%). The second most common cause of
AR was progressive AR due to previous commis-
surotomy of the aortic valve (30.6%). Advanced
preoperative clinical symptoms were observed more
commonly in group 1 (p < 0.05), and this result is
similar to those of previous reports [4, 7, 13]. This
result revealed that gradual dilatation of the LV
chamber, which is initially an essential compensatory
mechanism to chronic volume overload of LV, could
lead to severe LV dilatation accompanied by LV
dysfunction. These changes will cause permanent
functional impairment in patients, although the
amount of time needed for this to occur is unclear
and not the same for all patients. On the other hand,
it should be noted that not all patients with extreme
LV dilatation are severely symptomatic.
Our ﬁnding is consistent with these of Klodas
et al. [7], and Michel et al. [10] showing that ex-
treme LV dilatation is not an isolated abnormality;
rather, it is usually associated with larger end sys-
tolic dimension and lower LVEF when compared
with patients with smaller end diastolic dimension.
However, in our study, statistically signiﬁcant dif-
Table 3. Postoperative echocardiographic characteristics
Group 1 (n = 11) Group 2 (n = 34)
Variable Preop Postop Changea Preop Postop Changea
EF (%) 54.2 ± 9.8 56.5 ± 9.6 NS 68.2 ± 7.8 70.7 ± 4.7 0.05
LVDD (mm) 64.4 ± 8.2 53.3 ± 8.2 0.08 45.6 ± 5 40.5 ± 4.3 0.05
LVSD (mm) 43.4 ± 7.2 37.1 ± 6 NS 28.3 ± 7.4 24.3 ± 4.2 NS
Postop, postoperative; Preop, preoperative; EF, ejection fraction; LVDD, left ventricular end diastolic dimension; LVSD, left ventricular
end systolic dimension; NS, not signiﬁcant.
a Preop vs postop (p value). Data presented as means ± SD. p < 0.05 is signiﬁcant.
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ferences between the two groups were only seen in
ventricular EF (p < 0.05). Advanced symptomatic
status (NYHA class III/IV) was observed more
commonly in group 1, consistent with previous
observations [7, 9, 10].
Postoperative Characteristics
Overall, the 8.1% operative mortality is higher than
that of previous reports, in which operative mortality
was approximately 4% [5, 7, 9, 13]. However, oper-
ative mortality was not signiﬁcantly diﬀerent between
the two groups (Table 1). On multivariate analysis,
the only signiﬁcant predictor of operative mortality
was advanced symptomatic status (p < 0.04), con-
sistent with previous reports by Klodas et al. (7) and
Turina et al. [13]. Consequently, with regard to
operative mortality and expected improvement of LV
function, extreme LV dilatation that is more common
in severely symptomatic patients should not be con-
sidered a contraindication to surgery [7, 8, 10]. If
patients were subjected to surgical intervention be-
fore the development of severe functional impair-
ment, lower surgical mortality and a better
improvement of clinical symptoms were obtained.
Because of the small number of severely symptomatic
patients in our study and the relatively short-term
follow-up period, their predictive value and true long-
term survival cannot be determined. Postoperative
echocardiograms (approximately 1 year after opera-
tion) showed improvement of ventricular diameters
and function in both groups. However, these
improvements were signiﬁcant only in the LV end
diastolic dimension, which were more pronounced in
group 1, and not signiﬁcant in end systolic diameter
(Table 3). The current ﬁndings are consistent with
previous observations, that demonstrated a signiﬁ-
cant rate of improvement in LV size and function
postoperatively [7, 10, 13]. Although patients in
group 1 experienced a remarkable decrease in LV
diameters, they were more likely to display persistent
ventricular dilatation postoperatively than patients in
group 2 (p < 0.0003) (Table 2). This study suggests
that considerable dilatation of the LV chamber is not
completely reversible and it will lead to permanent
cardiac malfunction. Our results are supported by the
ﬁndings of Turina et al. [13] and Klodas et al. [7] who
performed studies on large series of patients with
extended follow-up.
Predictors of Postoperative LV Size and Function
Persistent postoperative LV dilatation has been
established as a marker of poor symptomatic out-
come and increased long-term mortality [2, 7], and
this may have had an impact on the survival patterns
of group 1.
End Diastolic Dimension. Our study demonstrated
that end diastolic dimension was a predictive factor
for persistent LV dysfunction (p < 0.05) (Table 2).
With regard to the relatively small number of patients
in this study (in comparison with previous studies,
especially in adults), this ﬁnding is in contrast with
previous reports [5, 7, 8, 11]. Klodas et al. [7, 8] and
Bonow et al. [1, 3] showed that end diastolic dimen-
sion was not predictive of the outcome and their
ﬁndings lend support to the concept that LV diastolic
dimension reﬂects the severity of the regurgitation
rather than the functional consequences of the
regurgitation on the myocardium. Therefore, the
persistent postoperative LV dilatation most likely
represents the eﬀect of associated abnormalities,
especially decreased EF and increased end systolic
dimension, and they conﬁrmed that only end systolic
dimension and EF have predictive value. Thus, fur-
ther studies on a larger number of pediatric patients
are needed to determine the true predictive value of
this important parameter.
End Systolic Dimension. Bonow et al. [2] and Klo-
das et al. [7] conﬁrmed the prognostic signiﬁcance of
the end systolic dimension on survival and postop-
erative ventricular function and dilatation. They
showed that end systolic dimension >55 mm was a
strong predictor of persistent ventricular dysfunction
and dilatation. Although most previous studies were
performed on adults, they support our ﬁnding that
preoperative end systolic dimension >4 SD above
normal is a signiﬁcant predictor of persistent ven-
tricular dilatation (p < 0.0007) and dysfunction
(p < 0.05).
LVEF. In this study, reduced LVEF (<50%) was a
strong predictor of postoperative dysfunction
(p < 0.008) and persistent LV dilatation (p < 0.01).
Similar results have been obtained from previous re-
ports in adults [7]. Consequently, this study is con-
sistent with previous reports demonstrating that
increased end systolic dimension and reduced LVEF
predict a higher rate of persistent postoperative LV
dilatation, conﬁrming the prognostic signiﬁcance of
these parameters on the outcome. [7, 10]
Predictors of Postoperative Clinical Status
LVEF. Our ﬁndings suggest that preoperative
echocardiographic EF is a powerful determinant of
postoperative symptomatic status (p < 0.03). This
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ﬁnding is consistent with reports of Bonow et al. [1]
and Klodas et al. [7] conﬁrming the predictive value
of reduced LVEF (<50%) as a poor prognostic
factor. Their ﬁndings, based on long-term follow-up
of a large patient cohort, suggest that preoperative
LVEF is a strong determinant of outcome and the
patients are aﬀorded signiﬁcantly improved post-
operative survival, symptomatic status, and LV
function when AVR is performed in the setting of
preserved systolic function. As is shown in this
study, EF also represents an essential element of the
clinical and hemodynamic decision-making process
in children.
Preoperative Functional Class
Turina et al. [13], Klodas et al. [7], and Michel et al.
[10] conﬁrmed that functional class has a profound
eﬀect on survival, irrespective of the contractile state.
Also, we found that advanced functional impairment
and worse LV performance were commonly seen in
patients with preoperative NYHA class III/IV but
statistically not signiﬁcant (Table 2). In this regard,
patients should preferentially be operated on early in
the symptomatic course of AR and before severe
symptoms develop. Unfortunately, the population of
our patients with NYHA class III/IV was relatively
small (8 of 49 patients), so postoperative outcome
and clinical status cannot be predicted accurately.
Further studies on a larger number of severely
symptomatic pediatric patients are needed to deter-
mine true predictive value of advanced clinical status.
Study Limitations
The use of echocardiography for determining ven-
tricular dimensions and function may be considered a
limitation. However, the methodology during the
period analyzed was stable, measurements of LV
dimensions were always guided by two-dimensional
echocardiography, and only high-quality measure-
ments were accepted. Similar data have been used in
previous studies and have served as the basis for
recommending the timing of AVR [5, 7, 11].
The patients considered in this study represented
only few percent of all people suﬀering from chronic
severe AR who have undergone valve replacement. In
other words, we did not represent clinical and he-
modynamic characteristics of patients with mild to
moderate AR. Because of the small number of pa-
tients and relatively short-term follow-up period, the
results must be considered with caution. Also, the
natural history and late survival could not be ana-
lyzed.
Conclusions
Our ﬁndings are consistent with those of previous
reports in which preoperative characteristics have
signiﬁcantly predicted early postoperative outcome,
thus indicating the prognostic utility of objective LV
size and performance assessment in the setting of AR.
In chronic AR, preoperative NYHA class III/IV is
the main predictor of surgical mortality. The presence
of NYHA class II/III symptoms should be a strong
incentive to consider closed follow-up of patients. In
addition, the hemodynamic state of myocardium,
represented by internal ventricular dimensions and
LVEF, was the best predictor of persistent ventricular
dysfunction and dilatation postoperatively. With re-
spect to ventricular size, both end systolic and end
diastolic dimension >4 SD above normal have
prognostic capacities for persistent LV dysfunction,
and these parameters can be considered as markers of
irreversible dysfunction. Importantly, echocardio-
graphically determined LVEF <50% is a powerful
predictor of permanent systolic dysfunction.
It is worth noting that clinical symptoms, systolic
LV function, and ventricular size are three indepen-
dent variables, and these parameters do not neces-
sarily progress concomitantly in patients with severe
chronic AR.
Ideally, surgical correction of aortic regurgitation
in children, similar to adults, should be performed
before severe LV dysfunction occurs. Operation can
be performed in severely symptomatic patients and/
or in those with greatly impaired hemodynamic
function, but surgical mortality is higher and post-
operative improvement is not optimal.
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